Verification of Access GI Monitor (CA 19-9) Assay on Beckman Coulter Unicel DXI 800
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Clinical Pathology"
DOI: 10.1093/ajcp/aqz112.036
Abstract: CA 19-9 antigen has been identified in patients with colorectal, pancreatic, bile duct, hepatocellular, stomach, and esophageal cancers. Noncancerous conditions that may elevate CA 19-9 levels include cirrhosis, cholangitis, hepatitis, pancreatitis, and nonmalignant gastrointestinal diseases.… read more here.
Keywords: unicel dxi; beckman coulter; coulter; coulter unicel ... See more keywords